HighMark Wealth Management Portfolio holdings
Top Buys
| 1 |
Protolabs
PRLB
|
+$145K |
| 2 |
SCTL
Societal CDMO, Inc. Common Stock
SCTL
|
+$111K |
| 3 |
AtriCure
ATRC
|
+$87.8K |
| 4 |
Tandem Diabetes Care
TNDM
|
+$78.8K |
| 5 |
iShares Core S&P Small-Cap ETF
IJR
|
+$67.8K |
Top Sells
| 1 |
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
|
+$2.16M |
| 2 |
Krystal Biotech
KRYS
|
+$2.02M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$637K |
| 4 |
iShares MSCI EAFE Value ETF
EFV
|
+$584K |
| 5 |
Halozyme
HALO
|
+$430K |
Sector Composition
| 1 | Healthcare | 7.9% |
| 2 | Financials | 4.48% |
| 3 | Technology | 3.39% |
| 4 | Consumer Discretionary | 2.75% |
| 5 | Industrials | 1.55% |
Similar funds
HighMark Wealth Management's Q3 2023 Portfolio in Review
As of Q3 2023, HighMark Wealth Management held 590 positions worth $121M, down 9.4% from $133M the previous quarter. Its ten largest holdings account for 74% of the portfolio.
HighMark Wealth Management withdrew a net $6.4M in Q3 2023, closing 24 positions and reducing 81 holdings. Its most notable exit was Reata Pharmaceuticals, Inc. Class A Common Stock, an estimated $2.16M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 7.9% of assets, down from 12% a quarter earlier, followed by Financials and Technology.
Against the trend, HighMark Wealth Management opened a new position in Insulet worth $19.9K.
- HighMark Wealth Management's largest Q3 2023 buy was Insulet: 125 shares worth $19.9K.
- HighMark Wealth Management added most to Protolabs in Q3 2023, an estimated $145K increase.
- HighMark Wealth Management's biggest Q3 2023 reduction was iShares Core S&P 500 ETF, cutting an estimated $637K.
- HighMark Wealth Management fully exited Reata Pharmaceuticals, Inc. Class A Common Stock in Q3 2023, selling an estimated $2.16M.
- HighMark Wealth Management's ten largest holdings make up 74% of its $121M portfolio in Q3 2023.
- HighMark Wealth Management opened 27 new positions and closed 24 in Q3 2023.
- HighMark Wealth Management's portfolio value fell 9.4% quarter-over-quarter to $121M.
Based on HighMark Wealth Management's 13F filing for Q3 2023, filed 18 Oct 2023.